While initially excited by Marco's appointment, I thought he was pretty average in his last presentation. Whether Elvis had already left the building, who knows.
Instead, I was more impressed with Donna as it was clear her knowledge and understanding of the business was exceptional. Her and Ravi continue to "stack" the data and ultimately, as a long-term investor, this is what will determine the value of PAR.
Also, I liked the way the company acknowledged their strategy of bringing someone in didn't work and then pivoted to Plexus and Angel Pond. This showed that they were prepared to humbly recognize their mistake and move on.
While I understand your opinion, I am ok with the current management.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-3520
-
-
- There are more pages in this discussion • 877 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 23.0¢ | $8.79K | 37.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 30801 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 16132 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 30801 | 0.230 |
10 | 148547 | 0.225 |
8 | 113266 | 0.220 |
5 | 64747 | 0.215 |
10 | 131788 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 16132 | 5 |
0.245 | 43833 | 5 |
0.250 | 20602 | 4 |
0.255 | 3356 | 1 |
0.260 | 31223 | 6 |
Last trade - 10.41am 13/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online